Does bivalirudin reduce major bleeding compared to heparins in patients with ST-segment elevation myocardial infarction transported emergently for primary percutaneous coronary intervention?
Bivalirudin started during transport for primary PCI reduces major bleeding compared to heparin strategies, but at the cost of increased stent thrombosis.
Bivalirudin, started during transport for primary PCI, reduces major bleeding compared with both patients treated with heparin only plus bailout GPI and patients treated with heparin and routine GPI, but increased stent thrombosis.
Zeymer et al. (Wed,) studied this question.